At the forefront of modern mental health treatments, Cope Psychiatry Clinic situated in the heart of Philadelphia, Pennsylvania, offers innovative ketamine infused therapies. The clinic specializes in reaching out and providing care to those individuals whose conditions are resistant to conventional healing therapies. Despite research indicating that only one in five individuals with mental health disorders seeks needed treatment, this pioneering Philadelphia clinic champions mental health by providing ketamine therapy for individuals grappling with challenging conditions like depression, anxiety, and chronic pain. We know that everyone’s journey is unique, so we offer an inviting atmosphere, convenient scheduling, and affordable pricing, creating an oasis of understanding and care. Are you interested in participating in a Psychedelics Clinical Trial? Connect with us, and we'll ensure you're the first to know when a trial becomes available in your region.

With a strong psychiatric foundation built over a span of more than 15 years, our clinic is led by Medical Director Dr. Raman Gopalakrishnan. Not new to advances in treatments, Dr. Gopalakrishnan, founded Riddle Psychiatry in 2012, and continues to work alongside the Centers of Psychiatric Excellence (COPE) to offer alternative, potentially life-changing ketamine treatments. Inspired by the principle of providing relief to those coping with resistant conditions, our team of professionals provides guidance and solutions to triumph over challenging disabilities. To ensure the efficacy of ketamine therapy, clients undergo a rigorous mental and physical health screening before infusions. These private, closely supervised treatments are designed with the utmost attention to comfort and safety and are followed by an observation period. Offering an additional ray of hope to the 17.52% of adults in Pennsylvania battling various mental health disorders, Cope Psychiatry Philadelphia remains rescilient in revolutionizing the field of mental health treatment by supplementing existing mainstream psychiatric practices or offering a hopeful alternative for those who’ve felt left behind by traditional methods.